Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer
Clinical trial NCT02592967 · TERMINATED
Trial details
- NCT number
- NCT02592967
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2018-08-14
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.